Chief technology officer

Vecima Announces Creation of Office of the CTO and Executive Leadership Changes

Retrieved on: 
Monday, July 20, 2020

Vecima Networks Inc. (TSX: VCM) announced today that it has made several organizational changes across the executive leadership team in alignment with the companys growth and operational objectives.

Key Points: 
  • Vecima Networks Inc. (TSX: VCM) announced today that it has made several organizational changes across the executive leadership team in alignment with the companys growth and operational objectives.
  • Mr. McCreery previously served as Chief Revenue Officer for Vecima, as well as managing operations for the Content Delivery & Storage business unit.
  • Prior to joining Concurrent, Mr. McCreery was Senior Vice President of Sales of North America at ARRIS for 14 years.
  • Mr. Colin Howlett has been appointed Chief Technology Officer and will lead the newly created Office of the CTO.

Signify Health Expands Leadership of Episodes of Care Division with Appointment of Chief Technology Officer and Executive Vice President of Clinical Operations

Retrieved on: 
Thursday, July 16, 2020

Josh Builder has joined Signify Health as Chief Technology Officer (CTO) and Laurel Douty as Executive Vice President of Clinical Operations.

Key Points: 
  • Josh Builder has joined Signify Health as Chief Technology Officer (CTO) and Laurel Douty as Executive Vice President of Clinical Operations.
  • Signify Health's Episodes of Care Division uses technology and services to align physical health with financial incentives and to facilitate collaboration across sites of care for a wide range of conditions and procedures.
  • Josh Builder, CTO,oversees all technology innovation, integration and operations for Signify Health's Episodes of Care Division.
  • Laurel Douty, EVP, leads all clinical operations for Signify Health's Episodes of Care Division with an emphasis on client-focused process improvements and change management.

Signify Health Expands Leadership of Episodes of Care Division with Appointment of Chief Technology Officer and Chief Operating Officer

Retrieved on: 
Thursday, July 16, 2020

Josh Builder has joined Signify Health as Chief Technology Officer (CTO) and Laurel Douty as Executive Vice President of Clinical Operations and Chief Operating Officer.

Key Points: 
  • Josh Builder has joined Signify Health as Chief Technology Officer (CTO) and Laurel Douty as Executive Vice President of Clinical Operations and Chief Operating Officer.
  • Signify Health's Episodes of Care Division uses technology and services to align physical health with financial incentives and to facilitate collaboration across sites of care for a wide range of conditions and procedures.
  • Josh Builder, CTO,oversees all technology innovation, integration and operations for Signify Health's Episodes of Care Division.
  • "I am honored to lead the evolution of Signify Health's Episodes of Care technology," said Builder.

Akerna Names David McCullough CTO

Retrieved on: 
Wednesday, July 1, 2020

DENVER, July 1, 2020 /PRNewswire/ --Akerna Corp. (Nasdaq: KERN), a leading provider of enterprise software solutions for the cannabis industry and developer of the cannabis industry's first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform), has named industry veteran David McCullough, chief technology officer (CTO), effective immediately.

Key Points: 
  • DENVER, July 1, 2020 /PRNewswire/ --Akerna Corp. (Nasdaq: KERN), a leading provider of enterprise software solutions for the cannabis industry and developer of the cannabis industry's first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform), has named industry veteran David McCullough, chief technology officer (CTO), effective immediately.
  • Being able to promote David to CTO demonstrates the strength of our bench and our commitment to team member development," said Jessica Billingsley, chief executive officer, Akerna.
  • As CTO, McCullough will leverage his 16 years of experience to drive the company's overall internal technology strategy.
  • McCulloughhas been with Akerna for more than 5 years, most recently serving as Akerna's executive vice president of product & engineering.

John Walsh Joins Zipari as Chief Technology Officer

Retrieved on: 
Thursday, June 18, 2020

Zipari , the first and only consumer experience platform built specifically for the health insurance industry, is pleased to announce that John Walsh has joined the company as Chief Technology Officer (CTO).

Key Points: 
  • Zipari , the first and only consumer experience platform built specifically for the health insurance industry, is pleased to announce that John Walsh has joined the company as Chief Technology Officer (CTO).
  • Walsh is the first CTO at Zipari and assumes responsibility for all technology including Architecture, Core Engineering, Infrastructure, Quality Assurance, Compliance and Technology Operations.
  • John brings the technology leadership and payer experience to lead Ziparis Consumer Experience (CX) Platform into the future.
  • Prior to joining Horizon BCBSNJ as VP and Chief Technology Officer in 2015, Walsh served at two other Blue Cross Blue Shield companies, as Vice President and Chief Architect at Excellus BCBS and as Chief Architect and Director of Data and Integration Services at HealthNow New York Inc. Before joining the healthcare industry, Walsh held technology leadership roles in the telecom industry as Chief Technology Officer with Callfinity and in the financial services industry at Fidelity Investments.

INCATech Promotes Jesse Osborne to Chief Technology Officer (CTO)

Retrieved on: 
Friday, June 5, 2020

RESTON, Va., June 5, 2020 /PRNewswire-PRWeb/ --INCATech is excited to announce that Jesse Osborne has been promoted as our new Chief Technology Officer (CTO).

Key Points: 
  • RESTON, Va., June 5, 2020 /PRNewswire-PRWeb/ --INCATech is excited to announce that Jesse Osborne has been promoted as our new Chief Technology Officer (CTO).
  • Jesse joined INCATech two years ago as our Geographic Information System (GIS) Practice Lead.
  • As CTO for INCATech, Jesse will be responsible for overseeing INCATech's technological vision, he will implement technology strategies and ensure that the technological resources are aligned with the business needs of the organization.
  • INCATech is an SBA 8(a) certified Woman Owned Small Business that has provided innovative technology to U.S. government and commercial customers for nearly a decade.

ContractPodAi Expands its C-Suite Executive Team by Appointing Seasoned Bay Area Technology Leader Anurag Malik as its New CTO

Retrieved on: 
Wednesday, June 3, 2020

ContractPodAi , the award-winning provider of AI-powered contract lifecycle management solutions, today announced the appointment of Anurag Malik as Chief Technology Officer (CTO).

Key Points: 
  • ContractPodAi , the award-winning provider of AI-powered contract lifecycle management solutions, today announced the appointment of Anurag Malik as Chief Technology Officer (CTO).
  • Malik brings over 20 years of experience scaling products and building technology teams for both start-ups and multi-billion corporations across a wide range of industries.
  • As the new CTO, Malik will focus on building the next generation of an AI driven dominant technology platform in the contract management space.
  • To learn more about how ContractPodAi is using artificial intelligence to power the contract lifecycle management process globally, visit ContractPodAi.com .

Aruvant Appoints Dr. Palaniappan as Chief Technology Officer

Retrieved on: 
Monday, June 1, 2020

NEW YORK andBASEL, Switzerland, June 1, 2020 /PRNewswire/ -- Aruvant Sciences Inc. (Aruvant), a clinical-stage biopharmaceutical company focused on developing and commercializing transformative therapies for the treatment of severe blood disorders, today announced the appointment of V. "Palani" Palaniappan, Ph.D. as chief technology officer (CTO) effective immediately.

Key Points: 
  • NEW YORK andBASEL, Switzerland, June 1, 2020 /PRNewswire/ -- Aruvant Sciences Inc. (Aruvant), a clinical-stage biopharmaceutical company focused on developing and commercializing transformative therapies for the treatment of severe blood disorders, today announced the appointment of V. "Palani" Palaniappan, Ph.D. as chief technology officer (CTO) effective immediately.
  • In this role, Dr. Palaniappan will be charged with growing Aruvant's technical and manufacturing capabilities for current and future programs.
  • "Dr. Palaniappan joins the team at an important time as we transition from academic to commercial manufacturing for ARU-1801, ourpotentially curative product candidate for individuals with sickle cell disease," saidWill Chou, M.D., chief executive officer ofAruvant.
  • Dr. Palaniappan joined Aruvant from Sarepta where he was senior vice president, head of global technical operations and head of the Andover and Burlington sites.

PatientKeeper Appoints John M. Kelly Chief Technology Officer

Retrieved on: 
Thursday, May 28, 2020

WALTHAM, Mass., May 28, 2020 /PRNewswire/ -- PatientKeeper, Inc. today announced the appointment of John M. Kelly as Chief Technology Officer (CTO).

Key Points: 
  • WALTHAM, Mass., May 28, 2020 /PRNewswire/ -- PatientKeeper, Inc. today announced the appointment of John M. Kelly as Chief Technology Officer (CTO).
  • As CTO, Kelly will lead PatientKeeper's engineering organization, comprising the software development, quality assurance, dev-ops, and UI/UX teams.
  • Kelly has more than 20 years of experience creating and aligning organizations to develop innovative software solutions for a range of industries including healthcare.
  • Hejoins PatientKeeper from Cigna , where he most recently held the title of IT Managing Director, serving as chief technologist for multiple business lines over 11 years.

GATT Technologies Announces €10.5M Series B Funding, Appointment of New CEO, and Expansion of Supervisory Board to Lead Company Through Next Development Stage

Retrieved on: 
Monday, May 18, 2020

Founder and current CEO Johan Bender will become responsible for R&D in his new role as CTO (Chief Technology Officer).

Key Points: 
  • Founder and current CEO Johan Bender will become responsible for R&D in his new role as CTO (Chief Technology Officer).
  • Proceeds of the investment will be used to support the next clinical trial phase and further development of applications of the Company's breakthrough hemostatic technology platform.
  • GATT Technologies' hemostats and sealants focus on controlling severe surgical bleedings as well as preventing and treating organ leakages.
  • Dr. Vlad Hogenhuis has assumed his role as board member with GATT Technologies effective May 1st, 2020.